卵巢癌腹水的中医药治疗进展  

Progress in Traditional Chinese Medicine Treatment of Ovarian Cancer Ascites

作　　者：李宁杰 苗辉 LI Ningjie;MIAO Hui(Department of Gynecological Minimally Invasive Ward,Zhumadian Hospital of Traditional Chinese Medicine,Zhumadian 463000,China)

机构地区：[1]驻马店市中医院妇科微创病区,河南驻马店463000

出　　处：《医学综述》2022年第21期4285-4289,共5页Medical Recapitulate

摘　　要：腹水是卵巢癌最常见的并发症之一,超过1/3的患者确诊时出现腹水,大多数患者在复发时伴有腹水。腹水一旦出现易引起多种不良反应,成为卵巢癌患者死亡的主要诱因。近年来针对卵巢癌腹水的中医药辨证研究不断增多,中医治疗方式也不断增加,如中药内服、中药外敷、针灸等联合放化疗在卵巢癌腹水的临床治疗中均取得了较好的效果。未来深入研究中医药治疗卵巢癌腹水的具体作用机制及进行更多高质量的临床随机对照研究,可为卵巢癌腹水的治疗提供可靠依据。Ascites is one of the most common complications of ovarian cancer,that more than one third of the patients have ascites at the time of diagnosis,and most patients have ascites at the time of recurrence.Once ascites appears,it easily causes a variety of adverse reactions and becomes the main cause of death in the ovarian cancer patients.In recent years,the dialectical research on ovarian cancer ascites with traditional Chinese medicine(TCM)has been increasing,and the TCM treatment methods have also been increasing,for example,oral administration of Chinese medicine,external application of Chinese medicine,acupuncture and moxibustion combined with radiotherapy and chemotherapy have achieved good results in the clinical treatment.In the future,in-depth studies on the specific mechanism of action of TCM in the treatment and more high-quality randomized controlled clinical studies will provide reliable evidence for the treatment of ovarian cancer ascites.

关 键 词：卵巢癌 腹水 中医药 

分 类 号：R273[医药卫生—中西医结合]